For adults struggling with weight, a weekly injection of tirzepatide offers real hope. Recent findings presented at the ...

Like semaglutide, tirzepatide targets the glucagon-like peptide-1 (GLP-1 ... Results were promising, with those taking 5-mg, 10-mg, and 15-mg weekly injections of tirzepatide losing weight ...

Adults with overweight or obesity plus prediabetes maintain most of their weight loss with tirzepatide at more than 3 years, ...

Tirzepatide linked to more GI issues than semaglutide in new study on weight-loss drugs without diabetes. Read more!

Eli Lilly’s Mounjaro (tirzepatide) was given the green light ... These examined Mounjaro in 5mg, 10mg and 15 mg doses in five clinical trials, used either as a stand-alone therapy or as an ...

Jaime Almandoz, MD, MBA, of UT Southwestern Medical Center, speaks on results of a study that investigated tirzepatide uptake ...

Prescribing of drugs between 2021 and 2023 shifted dramatically for both type 2 diabetes and weight loss for people with ...

Tirzepatide is approved for 3 indications in the US: type 2 diabetes, chronic weight management, and obstructive sleep apnea.

As the popularity of peptides continues to rise in 2025, fueled by the success of GLP-1 medications like Semaglutide and Tirzepatide, more individuals are exploring their potential health benefits ...

Tirzepatide dispensations increased rapidly among adults with T2D prescribed GLMs and among adults without diabetes prescribed WLMs.

Peptides, small chains of amino acids, have been hypothesized to play critical roles in various biological processes within organisms. Retatrutide and Tirzepatide have garnered significant ...

Zepbound is the first and only FDA-approved dual glucagon-like peptide-1 (GLP-1 ... patients taking 5mg, 10mg, and 15mg doses of tirzepatide once weekly lost an average of 15%, 19.5%, and 20.9 ...